MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sales of
pre-funded warrants
$22,676K
Proceeds from the
exercise of warrants for...
$7,870K
Proceeds from sales of
common stock
$3,310K
Net cash provided by
financing activities
$28,154K
Canceled cashflow
$5,702K
Net increase
(decrease) in cash, cash...
$18,959K
Canceled cashflow
$9,195K
something is missing
-$3,651K
Payments made for costs to
acquire capital
$2,051K
Impairment of intangible
assets
$2,503K
Accrued expenses
$415K
Accounts payable
$380K
Share-based compensation
$377K
Depreciation of fixed assets
$147K
Amortization of operating
lease right-of-use...
$98K
Amortization of intangible
assets
$5K
Redemption of debt
securities
$5,400K
Net cash used in
operating activities
-$6,084K
Net cash (used in)
provided by investing...
-$3,111K
Canceled cashflow
$3,925K
Canceled cashflow
$5,400K
Net loss
-$7,730K
Purchases of debt
securities
$8,500K
Prepaid expenses and
other current assets
$1,783K
Prepaid expenses -
noncurrent
$281K
Operating lease
obligations
-$124K
Amortization of
premiums/(accretion of discounts) on...
$71K
Accrued interest
receivable on promissory...
$20K
Purchases of fixed assets
$11K
Back
Back
Cash Flow
iBio, Inc. (IBIO)
iBio, Inc. (IBIO)
source: myfinsight.com